Bayer AG
XETRA:BAYN
Bayer AG
Other Assets
Bayer AG
Other Assets Peer Comparison
Competitive Other Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Other Assets
€32.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
13%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Other Assets
€17.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
MPH Health Care AG
XETRA:93M1
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Assets
€578.5m
|
CAGR 3-Years
30%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Other Assets?
Other Assets
32.3B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Other Assets amounts to 32.3B EUR.
What is Bayer AG's Other Assets growth rate?
Other Assets CAGR 10Y
13%
Over the last year, the Other Assets growth was -19%. The average annual Other Assets growth rates for Bayer AG have been -4% over the past three years , -3% over the past five years , and 13% over the past ten years .